China NT Pharma Group Co., Ltd.(HK:1011)
HK$0.19-0.02 (-8.10%)
HK:1011
China NT Pharma Group Co., Ltd. financials statements
HK$0.19
At close:-0.02 (-8.10%)
Want to see HK:1011 full AI Analyst Report?
China NT Pharma Group Co., Ltd. (1011) Financial Statements
2 Followers
China NT Pharma Group Co., Ltd. Financial Overview
China NT Pharma Group Co., Ltd.'s market cap is currently ¥346.74M. The company's EPS TTM is ¥-0.04; its P/E ratio is -4.61; and it has a dividend yield of 0.02%. China NT Pharma Group Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 24.16M | ¥ 37.96M | ¥ 7.37M | ¥ 207.09M | ¥ 226.70M |
| Gross Profit | ¥ 9.61M | ¥ 5.26M | ¥ 7.37M | ¥ 125.29M | ¥ 145.46M |
| Operating Income | ¥ -12.36M | ¥ -13.23M | ¥ -56.21M | ¥ -26.54M | ¥ -99.43M |
| EBITDA | ¥ -11.72M | ¥ -12.57M | ¥ 1.33M | ¥ 10.39M | ¥ -17.78M |
| Net Income | ¥ -26.04M | ¥ -53.36M | ¥ -143.59M | ¥ -66.41M | ¥ -149.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 7.22M | ¥ 9.62M | ¥ 1.52M | ¥ 5.93M | ¥ 9.44M |
| Total Assets | ¥ 347.50M | ¥ 334.07M | ¥ 329.12M | ¥ 1.01B | ¥ 955.36M |
| Total Debt | ¥ 316.83M | ¥ 375.95M | ¥ 344.94M | ¥ 826.45M | ¥ 832.11M |
| Net Debt | ¥ 309.61M | ¥ 366.33M | ¥ 343.42M | ¥ 820.52M | ¥ 822.67M |
| Total Liabilities | ¥ 621.45M | ¥ 733.18M | ¥ 668.69M | ¥ 1.25B | ¥ 1.17B |
| Stockholders' Equity | ¥ -273.74M | ¥ -399.11M | ¥ -339.56M | ¥ -241.66M | ¥ -211.38M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -24.71M | ¥ -9.24M | ¥ 37.58M | ¥ 31.72M | ¥ -135.42M |
| Operating Cash Flow | ¥ -24.55M | ¥ -9.07M | ¥ 50.48M | ¥ 36.21M | ¥ -134.78M |
| Investing Cash Flow | ¥ -154.88K | ¥ -189.00K | ¥ -22.14M | ¥ 4.53M | ¥ 257.81M |
| Financing Cash Flow | ¥ 24.05M | ¥ 12.65M | ¥ -28.97M | ¥ -46.68M | ¥ -124.80M |
Currency in CNY
